Genghis Lloyd-Harris

Dr. Genghis Lloyd-Harris is a high-net-worth investor based in London, United Kingdom. He is a Partner at Abingworth. He focuses on exits of venture investments via mergers and acquisitions and IPOs. Genghis’ current and past board positions include Avillion, GenSight Biologics, Healthcare Brands International, Novexel, Solexa, Synosia, Syntaxin and Wilson Therapeutics. He manages his own investments.